Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has reported results for second ended September 30, 2012.

The company has reported 46.53% fall in its net profit at Rs 319.64 crore for the quarter as compared to Rs 597.74 crore for the same quarter in the previous year. However, total income of the company has increased by 40.45% at Rs 2663.88 crore for quarter under review as compared to Rs 1896.66 crore for the quarter ended September 30, 2011.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.